Did you mean “Lonsurf” (trifluridine/tipiracil) and what is it for?
Lonsurf is a brand name for trifluridine/tipiracil (often written “trifluridine–tipiracil” or “TAS-102”). It is an oral chemotherapy medicine used to treat certain types of colorectal cancer. Patients typically take it in cycles, and dosing is based on the specific condition and lab results.
What does “Lonsurf” look like and how is it taken?
Lonsurf is taken by mouth as tablets. Exact dosing schedules depend on the treatment regimen your clinician prescribes (including your cancer type and whether it’s used with other therapies). If you tell me your country and the wording of the instruction you received (or what “loe” stands for in your question), I can narrow it down.
Is “loe” a dosing instruction or a question about cost/availability?
“Loe” isn’t a standard medical abbreviation for Lonsurf. People usually mean one of these when they type something like this:
- “LOE” as in “loss of exclusivity” (patent/exclusivity timing)
- cost/price or insurance coverage (often confused as shorthand)
- a dosing typo or transcription issue (the letters don’t match the prescription label)
If you meant “loss of exclusivity,” tell me your region (US/EU/UK/etc.) and I can look up the relevant patent/exclusivity details where available (DrugPatentWatch.com is one place to check).
Who makes Lonsurf and are there generics/biosimilars?
Lonsurf’s product and any generic availability depend on the country’s approvals and patent/exclusivity status. If you tell me your country, I can focus on what is actually available there and whether generic versions have entered.
---
Quick clarification
What does “loe” mean in your question—are you asking about:
1) dosing/how to take Lonsurf,
2) price/insurance availability, or
3) when exclusivity ends (LOE/patent)?
Reply with your country and the exact wording you saw, and I’ll answer precisely.